EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the “lung and large intestine stand in exterior-interior relationship” theory

Luwei Li, Hongmei Zhong, Yajie Wang, Zongying Pan, Shumei Xu, Shuai Li, Guilin Zeng, Weiwei Zhang, Jie Li, Lang He

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1341032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Luwei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Gastrointestinal Microbiome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study is aim to discern the Traditional Chinese Medicine (TCM) syndrome classifications relevant to immunotherapy sensitive in non-small cell lung cancer (NSCLC) patients, and to delineate intestinal microbiota biomarkers and impact that wield influence over the efficacy of NSCLC immunotherapy, grounded in the TCM theory of “lung and large intestine stand in exterior-interior relationship.” Methods The study cohort consisted of patients with advanced NSCLC who received treatment at the Oncology Department of Chengdu Fifth People’s Hospital. These patients were categorized into distinct TCM syndrome types and subsequently administered immune checkpoint inhibitors (ICIs), specifically PD-1 inhibitors. Stool specimens were collected from patients both prior to and following treatment. To scrutinize the differences in microbial gene sequences and species of the intestinal microbiota, 16S rRNA amplicon sequencing technology was employed. Additionally, peripheral blood samples were collected, and the analysis encompassed the assessment of T lymphocyte subsets and myeloid suppressor cell subsets via flow cytometry. Subsequently, alterations in the immune microenvironment pre- and post-treatment were thoroughly analyzed.

Results

The predominant clinical manifestations of advanced NSCLC patients encompassed spleen-lung Qi deficiency syndrome and Qi-Yin deficiency syndrome. Notably, the latter exhibited enhanced responsiveness to ICIs with a discernible amelioration of the immune microenvironment. Following ICIs treatment, significant variations in microbial abundance were identified among the three strains: Clostridia, Lachnospiraceae, and Lachnospirales, with a mutual dependency relationship. In the subset of patients manifesting positive PD-L1 expression and enduring therapeutic benefits, the study recorded marked increases in the ratios of CD3 + %, CD4 + %, and CD4 + /CD8 + within the T lymphocyte subsets. Conversely, reductions were observed in the ratios of CD8%, Treg/CD4 + , M-MDSC/MDSC, and G-MDSC/MDSC.

Conclusion

The strains Clostridia, Lachnospiraceae, and Lachnospirales emerge as potential biomarkers denoting the composition of the intestinal microbiota in the NSCLC therapy. The immunotherapy efficacy of ICIs markedly accentuates in patients displaying durable treatment benefits and those expressing positive PD-L1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsGastrointestinal MicrobiomeHumansImmune Checkpoint InhibitorsB7-H1 AntigenRNA, Ribosomal, 16SImmunotherapyProgrammed Cell Death 1 ReceptorLungTumor Microenvironment

Stichwörter der Autor:innen

TCM syndrome typebiomarkers of intestinal floraimmune microenvironmentimmunotherapylung and large intestinenon-small cell lung cancer

Substanzen

Immune Checkpoint InhibitorsB7-H1 AntigenRNA, Ribosomal, 16SProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Cancer Prevention and Treatment Institute of Chengdu, Department of Oncology, Chengdu Fifth People's Hospital (The Second Clinical Medical College), Affiliated Fifth People's Hospital of Chengdu University of Traditiona…
  • Center for Medicine Research and Translation, Chengdu Fifth People's Hospital, Chengdu, China.

Zitieren

APA

Li, L., Zhong, H., Wang, Y., Pan, Z., Xu, S., Li, S., Zeng, G., Zhang, W., Li, J., & He, L. (2024). Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the “lung and large intestine stand in exterior-interior relationship” theory. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1341032

Vancouver

Li L, Zhong H, Wang Y, Pan Z, Xu S, Li S, et al. Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the “lung and large intestine stand in exterior-interior relationship” theory. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1341032

BibTeX
@article{Li2024,
  author = {Li, Luwei and Zhong, Hongmei and Wang, Yajie and Pan, Zongying and Xu, Shumei and Li, Shuai and Zeng, Guilin and Zhang, Weiwei and Li, Jie and He, Lang},
  title = {Exploring the relationship between intestinal microbiota and immune checkpoint inhibitors in the treatment of non-small cell lung cancer: insights from the “lung and large intestine stand in exterior-interior relationship” theory},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1341032}
}
Kostenlos starten →